Pharmx Technologies Ltd
ASX:PHX
Balance Sheet
Balance Sheet Decomposition
Pharmx Technologies Ltd
Pharmx Technologies Ltd
Balance Sheet
Pharmx Technologies Ltd
| Jun-2001 | Jun-2002 | Jun-2003 | Jun-2004 | Jun-2005 | Jun-2006 | Jun-2007 | Jun-2008 | Jun-2009 | Jun-2010 | Jun-2011 | Jun-2012 | Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
2
|
0
|
2
|
2
|
4
|
4
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
10
|
8
|
5
|
2
|
2
|
6
|
6
|
13
|
13
|
|
| Cash |
0
|
2
|
0
|
2
|
2
|
4
|
4
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
8
|
5
|
2
|
2
|
6
|
5
|
13
|
13
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
9
|
12
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
13
|
0
|
|
| Total Receivables |
2
|
2
|
2
|
2
|
1
|
2
|
3
|
1
|
1
|
5
|
5
|
6
|
5
|
4
|
3
|
1
|
2
|
3
|
4
|
6
|
2
|
3
|
3
|
3
|
|
| Accounts Receivables |
1
|
2
|
1
|
2
|
1
|
2
|
3
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
4
|
1
|
1
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
5
|
5
|
5
|
4
|
2
|
0
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Inventory |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
1
|
0
|
0
|
0
|
1
|
4
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
3
|
3
|
2
|
1
|
0
|
7
|
0
|
|
| Total Current Assets |
3
|
4
|
3
|
5
|
3
|
6
|
8
|
7
|
5
|
6
|
7
|
9
|
14
|
16
|
15
|
13
|
12
|
11
|
9
|
10
|
10
|
9
|
23
|
16
|
|
| PP&E Net |
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| PP&E Gross |
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Accumulated Depreciation |
1
|
2
|
2
|
2
|
2
|
2
|
3
|
4
|
5
|
5
|
5
|
5
|
5
|
4
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
|
| Intangible Assets |
8
|
2
|
2
|
0
|
0
|
1
|
3
|
3
|
3
|
2
|
1
|
0
|
0
|
0
|
0
|
11
|
5
|
7
|
4
|
5
|
19
|
19
|
11
|
11
|
|
| Goodwill |
12
|
6
|
5
|
5
|
4
|
15
|
15
|
15
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Other Assets |
12
|
6
|
5
|
5
|
4
|
15
|
15
|
15
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
|
| Total Assets |
24
N/A
|
14
-42%
|
11
-21%
|
10
-5%
|
8
-22%
|
23
+188%
|
27
+16%
|
27
+1%
|
19
-30%
|
20
+4%
|
20
+0%
|
20
+2%
|
25
+25%
|
27
+8%
|
27
+0%
|
26
-4%
|
20
-24%
|
20
0%
|
15
-24%
|
19
+28%
|
31
+63%
|
31
-2%
|
37
+19%
|
30
-18%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
6
|
8
|
11
|
11
|
7
|
3
|
5
|
7
|
9
|
3
|
3
|
3
|
2
|
2
|
3
|
5
|
4
|
4
|
4
|
4
|
5
|
3
|
1
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
3
|
2
|
4
|
10
|
3
|
7
|
0
|
12
|
7
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
1
|
2
|
3
|
3
|
2
|
3
|
3
|
1
|
8
|
9
|
7
|
6
|
5
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
11
|
10
|
|
| Total Current Liabilities |
10
|
12
|
16
|
23
|
12
|
12
|
8
|
22
|
17
|
14
|
14
|
9
|
9
|
8
|
7
|
6
|
6
|
5
|
5
|
5
|
6
|
5
|
12
|
12
|
|
| Long-Term Debt |
1
|
0
|
1
|
0
|
7
|
7
|
11
|
0
|
0
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Minority Interest |
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Total Liabilities |
13
N/A
|
15
+15%
|
20
+34%
|
24
+21%
|
19
-22%
|
19
+3%
|
19
0%
|
22
+14%
|
17
-22%
|
17
-1%
|
15
-10%
|
10
-37%
|
9
-7%
|
8
-7%
|
7
-13%
|
6
-16%
|
6
-6%
|
5
-5%
|
5
0%
|
6
+9%
|
8
+41%
|
8
-10%
|
14
+89%
|
14
-3%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
55
|
61
|
61
|
65
|
73
|
74
|
77
|
78
|
85
|
85
|
85
|
85
|
86
|
86
|
86
|
86
|
86
|
86
|
86
|
90
|
98
|
98
|
98
|
94
|
|
| Retained Earnings |
44
|
62
|
70
|
79
|
84
|
70
|
70
|
73
|
83
|
82
|
81
|
75
|
69
|
67
|
66
|
66
|
72
|
72
|
77
|
77
|
75
|
75
|
76
|
78
|
|
| Total Equity |
11
N/A
|
1
N/A
|
9
-770%
|
14
-51%
|
11
+21%
|
4
N/A
|
8
+98%
|
5
-32%
|
2
-60%
|
3
+44%
|
5
+60%
|
11
+130%
|
16
+53%
|
19
+15%
|
20
+6%
|
20
0%
|
14
-30%
|
14
+2%
|
10
-33%
|
13
+38%
|
23
+74%
|
23
+1%
|
22
-4%
|
16
-28%
|
|
| Total Liabilities & Equity |
24
N/A
|
14
-42%
|
11
-21%
|
10
-5%
|
8
-22%
|
23
+188%
|
27
+16%
|
27
+1%
|
19
-30%
|
20
+4%
|
20
+0%
|
20
+2%
|
25
+25%
|
27
+8%
|
27
+0%
|
26
-4%
|
20
-24%
|
20
0%
|
15
-24%
|
19
+28%
|
31
+63%
|
31
-2%
|
37
+19%
|
30
-18%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
22
|
24
|
24
|
32
|
61
|
68
|
89
|
96
|
242
|
242
|
242
|
242
|
249
|
254
|
255
|
270
|
270
|
270
|
270
|
425
|
597
|
597
|
597
|
599
|
|